(Q42982848)

English

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study

scientific article published on 3 June 2010

Statements

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study (English)
Seung Phil Hong

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit